EFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXILO GLENMARK 600 MG/200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
EFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXILO GLENMARK 600 MG/200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Commercialized
Register Number
84409
Prescription Type
Diagnóstico Hospitalario
Authorization Date
Aug 5, 2019
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number84409
EMA Approved
No
Drug Classification
✓
Generic
Yes
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (3)
EFAVIRENZActive
Quantity: 600 mg
Name: EFAVIRENZ
EMTRICITABINAActive
Quantity: 200 mg
Name: EMTRICITABINA
TENOFOVIR DISOPROXILO FUMARATOActive
Quantity: 300 mg
Name: TENOFOVIR DISOPROXILO FUMARATO
ATC CLASSIFICATION (3)
J05A
J05AR
J05AR06